EUROPE: Pfizer and its partner BioNTech said today that the EU health regulator has recommended authorising the use of their bivalent Covid-19 shot as a booster in children aged five through 11.
The Omicron-tailored vaccine is already authorised by the EC for individuals aged 12 years and above.
The updated bivalent booster shot targets the original coronavirus strain as well as the BA.4 and BA.5 sub-variants of Omicron.
In October, European Medical Agency backed authorisation of Moderna’s Covid-19 tailored booster shots for 12 and above to further vaccination campaigns in the region.